Glaucoma and Alzheimer Disease: One Age-Related Neurodegenerative Disease of the Brain

@article{Mancino2018GlaucomaAA,
  title={Glaucoma and Alzheimer Disease: One Age-Related Neurodegenerative Disease of the Brain},
  author={R. Mancino and A. Martucci and M. Cesareo and C. Giannini and M. Corasaniti and G. Bagetta and C. Nucci},
  journal={Current Neuropharmacology},
  year={2018},
  volume={16},
  pages={971 - 977}
}
Background: Open Angle Glaucoma (POAG) is the leading causes of irreversible blindness worldwide. Elevated intraocular pressure is considered an important risk factor for glaucoma; however, a subset of patients experiences a progression of the disease even in presence of normal intraocular pressure values. This implies that risk factors other than intraocular pressure are involved in the pathogenesis of glaucoma. A possible relationship between glaucoma and neurodegenerative diseases such as… Expand
Retinal Degeneration and Alzheimer’s Disease: An Evolving Link
TLDR
Recent information on Aβ, p-tau, chronic inflammation, and iron dyshomeostasis as common pathogenic mechanisms linking the three degenerative conditions, andIron chelation as a common therapeutic option for these disorders are reviewed. Expand
Evaluating the neuroprotective impact of senolytic drugs on human vision
TLDR
It is suggested that senolytic drugs do not carry significant ocular toxicity and provide further support for additional evaluation of the potential neuroprotective effects of senolytics on glaucoma and other neurodegenerative diseases. Expand
Evaluating the neuroprotective impact of senolytic drugs on human vision
TLDR
It is suggested that senolytic drugs do not carry significant ocular toxicity and provide further support for additional evaluation of the potential neuroprotective effects of senolytics on glaucoma and other neurodegenerative diseases. Expand
[Comorbidity of Alzheimer's disease and gegontophtalmic pathology].
TLDR
It was shown that patients with Alzheimer's disease and glaucoma have more significant impairments compared to patients without concomitant ophthalmological pathology. Expand
Ocular Manifestations of Alzheimer's and Other Neurodegenerative Diseases: The Prospect of the Eye as a Tool for the Early Diagnosis of Alzheimer's Disease
TLDR
The visual abnormalities of Alzheimer's and other neurodegenerative diseases are discussed, focused on ocular functional-visual-structural biomarkers, retinal pathology, and potential novel diagnostic tools. Expand
Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer's disease
TLDR
Available literature on the ocular biomarkers in anterior and posterior segments of the eye including the cornea, aqueous humour (AH), crystalline lens, and retina in AD is reviewed to highlight the newer technological tools available for the detection of potential biomarker in the eye for early diagnosis of AD. Expand
Review of a new concept of glaucoma pathogenesis based on the glymphatic theory of cerebrospinal fluid circulation
TLDR
There is some clinical, including case-based, and epidemiological evidence for similarities between glaucomatous optic nerve/retinal injuries and AD, since both occur in the form of improper secretion of neurotoxic metabolites, and both are often diagnosed together. Expand
What is the optimal glaucoma treatment: reducing aqueous humour production or facilitating its outflow?
TLDR
The fact that IOP can differ so substantially between glaucoma groups encourages the search for additional mechanisms that may also lead toglaucomatous optic disc pathology and visual field damage. Expand
Evidence on neuroprotective properties of coenzyme Q10 in the treatment of glaucoma
TLDR
Coenzyme Q10, showing evidence in slowing or reversing pathological changes typical of the disease, has been proposed as a potential neuroprotective agent in glaucoma and the possible mechanisms of action are described. Expand
Glaucoma Is Not Associated With Alzheimer's Disease or Dementia: A Meta-Analysis of Cohort Studies
  • Wenmei Zhao, Xia Lv, +8 authors Jinyong Tian
  • Medicine
  • Frontiers in Medicine
  • 2021
Background: Previous studies evaluating the relationships of glaucoma with Alzheimer's disease (AD) and dementia showed inconsistent results. We performed a meta-analysis of cohort studies toExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 90 REFERENCES
Glaucoma: An Extension of Various Chronic Neurodegenerative Disorders
The eyes are the window of the brain; various pathologies of the eyes can be explained on the basis of neurological disorders and vice versa. Today, our only approach for the management of glaucomaExpand
Links among glaucoma, neurodegenerative, and vascular diseases of the central nervous system.
TLDR
Recent evidence supporting pathological links between glaucoma and disorders of the central nervous system (CNS) is discussed, including Alzheimer's disease and cerebrovascular diseases. Expand
Alzheimer’s disease and glaucoma: Is there a causal relationship?
TLDR
It is hypothesised that there may be a causal relationship between AD and glaucoma that may be explained by decreased cerebrospinal fluid pressure (CSFP) in patients with AD, and an abnormal high trans-lamina cribrosa pressure difference may explain why patients withAD have a greater risk for developing glAUcoma. Expand
Glaucoma, Alzheimer's Disease, and Parkinson's Disease: An 8-Year Population-Based Follow-Up Study
TLDR
In elderly patients, POAG is a significant predictor of AD, butPOAG is not a predictor of PD. Expand
Senile Dementia and Glaucoma: Evidence for a Common Link
TLDR
Evidence suggests the need to further study links between the two diseases, as this could prove instrumental in understanding their overlapping pathophysiology and developing directed therapies for both diseases. Expand
Glaucoma progression associated with altered cerebral spinal fluid levels of amyloid beta and tau proteins
TLDR
A glaucoma patient with medically controlled intraocular pressure who experienced disease progression concomitantly with the onset of mild cognitive impairment (MCI) and positivity for cerebral spinal fluid (CSF) markers of AD is described. Expand
High Occurrence Rate of Glaucoma among Patients with Alzheimer’s Disease
TLDR
Visual field defects and/or optic disc cupping compatible with the diagnosis of glaucoma were found in 29 out of 112 patients with Alzheimer’s disease and ocular hypertension with normal visual fields and normal optic nerve heads was not found in patients with AD. Expand
The aging eye: common degenerative mechanisms between the Alzheimer's brain and retinal disease.
  • J. Sivak
  • Biology, Medicine
  • Investigative ophthalmology & visual science
  • 2013
TLDR
Common mechanisms that appear to underlie all three diseases are explored here, as well as potential use of the retina as a biomarker for AD diagnosis and progression, and past and current efforts to transfer therapeutic strategies between diseases are discussed. Expand
Glaucoma: ocular Alzheimer's disease?
  • S. Mckinnon
  • Medicine
  • Frontiers in bioscience : a journal and virtual library
  • 2003
TLDR
In rat glaucoma models, it is shown that caspase-3, a major effector of the apoptotic cascade, is activated in RGCs and cleaves amyloid precursor protein (APP) to produce neurotoxic fragments that includeAmyloid-beta, which suggests a new hypothesis for RGC death in glAUcoma involving chronic amyloids-beta neurotoxicity, mimicking AD at the molecular level. Expand
Age-related macular degeneration, glaucoma and Alzheimer’s disease: amyloidogenic diseases with the same glymphatic background?
TLDR
It is proposed that failure of the so-called ‘glymphatic system’ may be a novel link underlying increased Ab accumulation in AMD, glaucoma and AD. Expand
...
1
2
3
4
5
...